{
    "eid": "2-s2.0-85071065885",
    "title": "Safety of direct oral anticoagulants in patients with cirrhosis: A systematic review and meta-analysis",
    "cover-date": "2019-08-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Medicine (all)",
            "@code": "2700",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [],
    "authors": [
        "K. Lapumnuaypol",
        "C. Dimaria",
        "T. Chiasakul"
    ],
    "citedby-count": 8,
    "ref-count": 30,
    "ref-list": [
        "Venous thromboembolism in patients with liver diseases",
        "The risk of venous thromboembolism in patients with cirrhosis",
        "Systematic review: Portal vein thrombosis in cirrhosis",
        "What we should know about portal vein thrombosis in cirrhotic patients: A changing perspective",
        "Impact of untreated portal vein thrombosis on pre and post liver transplant outcomes in cirrhosis",
        "Evaluation of venous thromboembolism prophylaxis in patients with chronic liver disease",
        "Epidemiology of atrial fibrillation in patients with cirrhosis and clinical significance",
        "2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation",
        "New oral anticoagulants: Their advantages and disadvantages compared with Vitamin K antagonists in the prevention and treatment of patients with thromboembolic events",
        "Oral rivaroxaban for symptomatic venous thromboembolism",
        "Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism",
        "Evaluation of the novel factor xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: Design and rationale for the effective anticoagulation with factor xa next generation in atrial fibrillation-thrombolysis in myocardial infarction study 48 (engage af-timi 48)",
        "Apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation (Aristotle) trial: Design and rationale",
        "Rivaroxaban versus warfarin in nonvalvular atrial fibrillation",
        "Dabigatran versus warfarin in the treatment of acute venous thromboembolism",
        "Measuring inconsistency in meta-analyses",
        "Safety of direct oral anticoagulants vs warfarin in patients with chronic liver disease and atrial fibrillation",
        "Randomized controlled trial of rivaroxaban versus warfarin in the management of acute non-neoplastic portal vein thrombosis",
        "The efficacy and safety of direct oral anticoagulants vs traditional anticoagulants in cirrhosis",
        "Direct oral anticoagulants in cirrhosis patients pose similar risks of bleeding when compared to traditional anticoagulation",
        "Efficacy and safety of edoxaban for treatment of portal vein thrombosis following danaparoid sodium in patients with liver cirrhosis",
        "Subcommittee on control of anticoagulation of the scientific, standardization committee of the international society on thrombosis and haemostasis definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients",
        "Anticoagulation in cirrhosis: A new paradigm?",
        "Risk of venous thromboembolism in patients with chronic liver disease and the utility of venous thromboembolism prophylaxis",
        "The international normalized ratio to prioritize patients for liver transplantation: Problems and possible solutions",
        "Routine coagulation assays underestimate levels of antithrombin-dependent drugs but not of direct anticoagulant drugs in plasma from patients with cirrhosis",
        "Risk of drug-induced liver injury with the new oral anticoagulants: Systematic review and meta-analysis",
        "Major bleeding with Vitamin K antagonists or direct oral anticoagulants in real-life",
        "Novel oral anticoagulants in atrial fibrillation: A meta-analysis of large, randomized, controlled trials vs warfarin"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Philadelphia",
            "@id": "60022826",
            "affilname": "Albert Einstein Medical Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022826",
            "affiliation-country": "United States"
        }
    ],
    "funding": []
}